查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575037

功能服务提供者 (FSP) 市场，按类型、按疾病类型、按最终用户、按国家和地区划分 - 2024-2032 年的行业分析、市场规模、市场份额和预测

Functional Service Providers (FSP) Market, By Type, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年，功能服务供应商 (FSP) 市场规模为 147.3043 亿美元，2024 年至 2032 年复合年增长率为 8.30%。

功能服务供应商（FSP）市场-市场动态

临床试验和医疗保健领域外包需求的成长预计将推动市场需求

医疗保健公司越来越多地将非核心职能外包给 FSP，以专注于其主要业务目标、降低营运成本并提高效率。随着临床试验变得更加复杂和全球化，FSP 提供专业知识和资源，帮助应对监管要求和后勤挑战。此外，人工智慧、巨量资料分析和数位健康解决方案等先进技术的整合增强了金融服务提供者的能力，使其服务对客户更具吸引力。

FSP 还利用其专业知识、既定流程和技术提供经济高效的解决方案，使客户组织能够节省营运成本。向以患者为中心的护理模式和个人化医疗的转变鼓励采用可以支持定制临床开发和患者参与策略的 FSP。此外，製药和生技公司对研发的投资不断增加，推动了对 FSP 服务的需求，以促进药物开发并将新疗法推向市场。

功能服务提供者 (FSP) 市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.30% 左右的复合年增长率成长

根据类型细分，由于临床试验对 FSP 的高需求，预计临床试验设计和监测细分市场将在 2023 年显示最大的市场份额。

根据疾病类型细分，由于製药和生物技术公司之间的合作伙伴关係不断加强，肿瘤学细分市场将成为 2023 年领先的疾病类型细分市场。

根据最终用户细分，由于研究支出和功能服务的使用不断增加，生物製药公司细分市场在 2023 年成为领先的最终用户细分市场。

从地区来看，由于医疗产业拥有先进技术，北美将成为 2023 年的主要收入来源。

功能服务提供者 (FSP) 市场区隔分析：

全球功能服务提供者 (FSP) 市场根据类型、疾病类型、最终用户和区域进行细分。

市场依类型分为五大类：临床试验设计与监测、资料管理、药物警戒、医学写作等。临床试验设计和监测领域占据市场主导地位。即时管理中的技术采用和监控优势正在支持市场成长。

市场依疾病类型分为六类：肿瘤、传染病、心血管疾病、神经系统疾病、免疫学等。肿瘤学领域在市场上占据主导地位。 CRO 和生物製药公司投资于泌尿科、血液学疾病专业知识的研究，这正在提振细分市场的需求。

根据最终用户，市场分为三类：生物製药公司、CRO 等。生物製药公司细分市场占据主导地位，预计在预测期内将保持其高度主导地位。申办者和 FSP 之间不断加强的合作策略正在提高临床开发的综合方法。

功能服务提供者 (FSP) 市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美，尤其是美国，由于製药和生物技术公司高度集中，以及临床研究和药物开发的大量投资，成为 FSP 服务的最大市场。受政府对临床研究的大力支持、众多生物技术公司以及复杂的监管环境的推动，欧洲是 FSP 服务的另一个重要市场。在临床试验数量不断增加和营运成本降低的推动下，亚太地区的 FSP 市场正在快速成长。

功能服务供应商（FSP）市场-竞争格局：

功能服务提供者 (FSP) 市场竞争非常激烈，有各种各样的公司为製药、生物技术和临床研究组织提供专业服务。公司正在大力投资科技以增强其 FSP 产品。这包括利用人工智慧、巨量资料分析和基于云端的平台来优化临床试验营运、资料管理和患者招募。 FSP 供应商正在扩大其地理覆盖范围，以利用亚太地区（中国、印度）、拉丁美洲和东欧等新兴市场不断增长的临床研究活动。此次扩张使我们能够获得更广泛的患者群体和具有成本效益的解决方案。

2023 年 1 月，Premier Research 与 Centogene NV 合作，为临床试验提供端对端支援。

2022年12月，在生物统计学方面拥有丰富经验的Everest Clinical Research收购了Brightech International以扩大业务。

目录

第 1 章：功能服务提供者 (FSP) 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的功能服务提供者 (FSP) 市场片段
    • 按疾病类型分類的功能服务提供者 (FSP) 市场片段
    • 最终用户的功能服务提供者 (FSP) 市场片段
    • 按国家/地区分類的功能服务提供者 (FSP) 市场片段
    • 按地区分類的功能服务提供者 (FSP) 市场片段
  • 竞争洞察

第 3 章：功能服务提供者 (FSP) 主要市场趋势

  • 功能服务提供者 (FSP) 市场驱动因素
    • 市场驱动因素的影响分析
  • 功能服务提供者 (FSP) 市场限制
    • 市场限制影响分析
  • 功能服务提供者 (FSP) 市场机会
  • 功能服务提供者（FSP）市场未来趋势

第 4 章：功能服务提供者 (FSP) 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：功能服务提供者 (FSP) 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：功能服务供应商 (FSP) 市场格局

  • 2023 年功能服务提供者 (FSP) 市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：功能服务提供者 (FSP) 市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 临床试验设计与监测
    • 资料管理
    • 药物警戒
    • 医学写作
    • 其他的

第 8 章：功能服务提供者 (FSP) 市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 肿瘤学
    • 传染病
    • 心血管疾病
    • 神经系统疾病
    • 免疫学
    • 其他的

第 9 章：功能服务提供者 (FSP) 市场 - 按下最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 生物製药公司
    • 合约研究组织
    • 其他的

第 10 章：功能服务提供者 (FSP) 市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美功能服务供应商 (FSP) 主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲功能服务供应商 (FSP) 主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区功能服务供应商（FSP）主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲功能服务供应商 (FSP) 主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 功能服务供应商 (FSP) 中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 功能服务提供者 (FSP) 产业

  • 竞争仪表板
  • 公司简介
    • IQVIA
    • Labcorp Drug Development
    • Parexel
    • ICON plc
    • Everest Clinical Research
    • Thermo Fisher Scientific
    • Syneos Health
    • Medpace
    • Charles River Laboratories
    • KCR
    • Worldwide Clinical Trials
    • Veristat
    • Celerion
    • Pharm-Olam
    • Premier Research
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4035

REPORT HIGHLIGHT

Functional Service Providers (FSP) Market size was valued at USD 14,730.43 Million in 2023, expanding at a CAGR of 8.30% from 2024 to 2032.

A Functional Service Provider (FSP) is a type of outsourcing model commonly used in the pharmaceutical and clinical research industries. Under this model, companies like pharmaceutical firms, biotechnology companies, and clinical research organizations (CROs) outsource specific functions or activities to a third-party service provider.

Functional Service Providers (FSP) Market- Market Dynamics

Rising demand for outsourcing in clinical trials and healthcare sector is expected to propel market demand

Healthcare companies are increasingly outsourcing non-core functions to FSPs to focus on their primary business objectives, reduce operational costs, and enhance efficiency. As clinical trials become more complex and globalized, FSPs offer expertise and resources that help navigate regulatory requirements and logistical challenges. Also, the integration of advanced technologies, such as artificial intelligence, big data analytics, and digital health solutions, enhances the capabilities of FSPs, making their services more attractive to clients.

FSPs also provide cost-effective solutions by leveraging their expertise, established processes, and technologies, allowing client organizations to save on operational costs. The shift toward patient-centric care models and personalized medicine encourages the adoption of FSPs that can support tailored clinical development and patient engagement strategies. In addition, growing investments in research and development by pharmaceutical and biotech companies drive the demand for FSP services to facilitate drug development and bring new therapies to market.

Functional Service Providers (FSP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.30% over the forecast period (2024-2032)

Based on Type segmentation, the clinical trial design & monitoring segment was predicted to show maximum market share in the year 2023, owing to high demand for FSP from clinical trials.

Based on Disease Type segmentation, oncology segment was the leading Disease Type segment in 2023, due to the rising partnerships between pharma & biotech companies.

Based on End User segmentation, biopharmaceutical companies segment was the leading End User segment in 2023, due to the increasing research spending & use of functional services.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of advanced tech in the medical industry.

Functional Service Providers (FSP) Market- Segmentation Analysis:

Global Functional Service Providers (FSP) Market is segmented on the basis of Type, Disease Type, End User, and Region.

The market is divided into five categories based on Type: clinical trial design & monitoring, data management, pharmacovigilance, medical writing, and others. The clinical trial design & monitoring segment dominates the market. Technology adoption & monitoring benefits in real time management is supporting market growth.

The market is divided into six categories based on Disease Type: oncology, infectious diseases, cardiovascular diseases, neurological diseases, immunology, and others. The oncology segment dominates the market. CROs and biopharma companies investing in research to expertise in urology, hematology disorders which is boosting segment demand.

The market is divided into three categories based on End User: biopharmaceutical companies, CROs, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing collaborative strategy between sponsors and FSPs is raising integrated approach to clinical development.

Functional Service Providers (FSP) Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, especially the United States, is the largest market for FSP services due to the high concentration of pharmaceutical and biotechnology companies, as well as significant investments in clinical research and drug development. Europe is another prominent market for FSP services, driven by strong government support for clinical research, many biotechnology firms, and a complex regulatory environment. The Asia-Pacific region is experiencing rapid growth in the FSP market, fueled by the increasing number of clinical trials, lower operational costs.

Functional Service Providers (FSP) Market- Competitive Landscape:

The Functional Service Provider (FSP) market is highly competitive, with a diverse set of companies offering specialized services to pharmaceutical, biotechnology, and clinical research organizations. Companies are investing heavily in technology to enhance their FSP offerings. This includes leveraging artificial intelligence, big data analytics, and cloud-based platforms to optimize clinical trial operations, data management, and patient recruitment. FSP providers are expanding their geographic footprint to tap into the growing clinical research activity in emerging markets such as Asia-Pacific (China, India), Latin America, and Eastern Europe. This expansion enables access to a broader patient pool and cost-effective solutions.

In January 2023, Premier Research and Centogene N.V. collaborated to offer end-to-end support in clinical trials.

In December 2022, Everest Clinical Research with high experience in biostatistics acquired Brightech International to expand their business.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET KEY PLAYERS

  • IQVIA
  • Labcorp Drug Development
  • Parexel
  • ICON plc
  • Everest Clinical Research
  • Thermo Fisher Scientific
  • Syneos Health
  • Medpace
  • Charles River Laboratories
  • KCR
  • Worldwide Clinical Trials
  • Veristat
  • Celerion
  • Pharm-Olam
  • Premier Research
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Clinical trial design & monitoring
  • Data management
  • Pharmacovigilance
  • Medical writing
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Infectious diseases
  • Cardiovascular diseases
  • Neurological diseases
  • Immunology
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • CROs
  • Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Functional Service Providers (FSP) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Functional Service Providers (FSP) Market Snippet by Type
    • 2.1.2. Functional Service Providers (FSP) Market Snippet by Disease Type
    • 2.1.3. Functional Service Providers (FSP) Market Snippet by End User
    • 2.1.4. Functional Service Providers (FSP) Market Snippet by Country
    • 2.1.5. Functional Service Providers (FSP) Market Snippet by Region
  • 2.2. Competitive Insights

3. Functional Service Providers (FSP) Key Market Trends

  • 3.1. Functional Service Providers (FSP) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Functional Service Providers (FSP) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Functional Service Providers (FSP) Market Opportunities
  • 3.4. Functional Service Providers (FSP) Market Future Trends

4. Functional Service Providers (FSP) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Functional Service Providers (FSP) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Functional Service Providers (FSP) Market Landscape

  • 6.1. Functional Service Providers (FSP) Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Functional Service Providers (FSP) Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Clinical trial design & monitoring
    • 7.1.3. Data management
    • 7.1.4. Pharmacovigilance
    • 7.1.5. Medical writing
    • 7.1.6. Others

8. Functional Service Providers (FSP) Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Infectious diseases
    • 8.1.4. Cardiovascular diseases
    • 8.1.5. Neurological diseases
    • 8.1.6. Immunology
    • 8.1.7. Others

9. Functional Service Providers (FSP) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical Companies
    • 9.1.3. CROs
    • 9.1.4. Others

10. Functional Service Providers (FSP) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Functional Service Providers (FSP) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Functional Service Providers (FSP) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Functional Service Providers (FSP) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Functional Service Providers (FSP) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Functional Service Providers (FSP) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Functional Service Providers (FSP) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. IQVIA
    • 11.2.2. Labcorp Drug Development
    • 11.2.3. Parexel
    • 11.2.4. ICON plc
    • 11.2.5. Everest Clinical Research
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. Syneos Health
    • 11.2.8. Medpace
    • 11.2.9. Charles River Laboratories
    • 11.2.10. KCR
    • 11.2.11. Worldwide Clinical Trials
    • 11.2.12. Veristat
    • 11.2.13. Celerion
    • 11.2.14. Pharm-Olam
    • 11.2.15. Premier Research
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us